How to measure and model cardiovascular aging

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Molecular Biology

Background:

• Acquired cardiovascular diseases are prevalent in older populations.
• Aging processes offer insights into cardiovascular pathophysiology.
• Understanding cardiovascular aging aids in personalized risk assessment and preventative therapies.

Purpose of the Study:

• To review key molecular mechanisms of cardiovascular aging.
• To explore the association between aging phenomena and cardiovascular disease.
• To discuss future directions in cardiovascular aging research.

Main Methods:

• Review of literature on molecular mechanisms of aging (telomere attrition, cellular senescence, epigenetic modifications, mitochondrial dysfunction).
• Examination of links between these aging mechanisms and cardiovascular disease markers (endothelial dysfunction, systemic inflammation).
• Discussion of current clinical, laboratory, and imaging techniques for measuring cardiovascular aging.

Main Results:

• Telomere attrition, cellular senescence, epigenetic modifications, and mitochondrial dysfunction are key molecular aging mechanisms.
• These mechanisms contribute to cardiovascular disease via endothelial dysfunction and systemic inflammation.
• Clinical, laboratory, and imaging techniques can measure these aging-related cardiovascular changes.

Conclusions:

• Cardiovascular aging is influenced by specific molecular mechanisms.
• These mechanisms are clinically measurable and linked to cardiovascular disease.
• Future cardiovascular aging models require integration of diverse patient data, leveraging AI and machine learning.